Understanding cancer-related fatigue in survivors
Official title: Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors
Run by Wake Forest University Health Sciences · NCT06634381 · Data updated 2026-11-12
This study looks at how cancer-related fatigue affects survivors and how they talk about it with their doctors to help improve communication and support.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Drugs / interventions | immunotherapy |
| Locations | 3 sites (Charlotte, North Carolina and 2 other locations) |
| Status | Recruiting |
| Started | March 12, 2025 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT06634381 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have completed cancer treatment more than six months ago and report significant fatigue.
✕Probably not a fit
Patients currently undergoing cancer treatment or those without detectable cancer but not experiencing fatigue may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational pilot study aims to explore how cancer-related fatigue impacts survivors and how it is communicated with healthcare providers. Participants will include adults who have completed cancer treatment over six months ago and are experiencing fatigue. The study will involve a six-minute walk test, surveys, and virtual interviews with both cancer survivors and clinicians to gather qualitative and quantitative data. The findings will be used to create an educational visual aid to facilitate discussions about managing cancer-related fatigue.
Why it matters
Potential benefit: If successful, this study could enhance communication between cancer survivors and their healthcare providers, leading to better management of cancer-related fatigue.
How similar studies have gone: While studies on cancer-related fatigue exist, this mixed methods approach focusing on survivor-provider communication is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ability to comply with study procedures for the duration of the study Survivors: * Written informed consent and HIPAA authorization for release of personal information * Ability to read/write, understand and converse in English without the need for an interpreter * Men and women aged ≥ 18 years at the time of consent * History of at least one visit for the purpose of monitoring long term care post curative treatment at LCH and/or the Charlotte or Winston-Salem campuses of AHWFBCCC * Completed curative treatment \> 6 months ago for any cancer type, with no detectable evidence of cancer * Self-reported tiredness, exhaustion, or weakness (i.e. fatigue) score of ≥ 4 on the Numerical Rating Scale * Adjuvant endocrine therapy to reduce the risk of cancer returning is acceptable (i.e. tamoxifen or aromatase inhibitors). Clinicians: \- Currently see oncology patients (any cancer type) for survivorship care at LCH and/or the Charlotte or Winston-Salem campuses of AHWFBCCC Exclusion Criteria: Survivors: * Continuing maintenance therapy or other cancer-related treatment (i.e. immunotherapy) * History of or current untreated Major Depressive Disorders or untreated severe depression * Hemoglobin \<11g/dL at last CBC SOC lab collection * History/diagnosis of dementia * Factors or conditions, for which participation may (1) not be in the best interest or (2) interfere with study assessment results (e.g. medical comorbidities, primary brain tumor/metastases) * No access to internet/Wi-Fi Clinicians: \- None
Where it's running
-
Levine Childrens Hospital Pediatric Cancer and Blood Disorders
Charlotte, North Carolina, United States Recruiting -
Levine Cancer Institute
Charlotte, North Carolina, United States Recruiting -
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Dori Beeler, PhD — Atrium Health Wake Forest Baptist Comprehensive Cancer Center
- Study coordinator: Megan Lattanze
- Email: Megan.Lattanze@advocatehealth.org
- Phone: (980) 442-4239
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Micro-choice-based approach to fatigue management
A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.
-
HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults
This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.
-
See if Nuvastatic helps with cancer-related fatigue in colon cancer patients on first-line chemotherapy
This trial tests whether Nuvastatic can lessen fatigue in adults with colon cancer who are receiving their first round of chemotherapy, compared to placebo.
-
Balance and gait in multiple sclerosis: linking motion data to function
Researchers will see if precise motion measurements of balance and walking relate to everyday functional tests in adults with MS.
-
Relaxation and breathing techniques to help with breathlessness and tiredness in cancer patients in palliative care
This study tests whether progressive muscle relaxation or deep breathing exercises can reduce dyspnea and fatigue and improve self-care in adults with cancer receiving palliative care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.